BAY 58-2667 Hydrochloride, Catalog: 2027

IN STOCK!
US$0.00

Alternate Name 4-((4-carboxybutyl)(2-((4-phenethylbenzol)- oxy)phenethyl)amino)methyl(benzoic) acid; BAY582667; cinaciguat

PRODUCT SUMMARY

Cat # +Size 2027-1

Size 1 mg

Alternate Names 4-((4-carboxybutyl)(2-((4-phenethylbenzol)- oxy)phenethyl)amino)methyl(benzoic) acid; BAY582667; cinaciguat

Appearance White solid

CAS # 1240669-95-7

Molecular Formula C₃₆H₃₉NO₅.HCl

Molecular Weight 602.16

Purity ≥ 98% by NMR

Solubility DMSO

SMILES C1=CC=C(C=C1)CCC2=CC=C(C=C2)COC3=CC=CC=C3CCN(CCCCC(=O)O)CC4=CC=C(C=C4)C(=O)O.Cl

InChi InChI=1S/C36H39NO5.ClH/c38-35(39)12-6-7-24-37(26-30-19-21-33(22-20-30)36(40)41)25-23-32-10-4-5-11-34(32)42-27-31-17-15-29(16-18-31)14-13-28-8-2-1-3-9-28;/h1-5,8-11,15-22H,6-7,12-14,23-27H2,(H,38,39)(H,40,41);1H

InChi Key LLHMBJOVHATVSP-UHFFFAOYSA-N

PubChem CID 10031513

Storage Conditions -20°C

Shipping Conditions Gel Pack

USAGE For Research Use Only! Not For Use in Humans.

Handling Do not take it internally. Wear a glove and mask when handling the product. Protect from air and moisture.

DESCRIPTION

A nitric oxide (NO)- and heme-independent soluble guanylyl cyclase activator. Displays potent cardiovascular effects. Improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure. Exhibits potent vasodilator and antiplatelet activity.